Compassionate Use Pathways
Compassionate Use Pathways is a regulatory mechanism under investigational device exemptions that permits the use of unapproved medical devices for individual patients with serious or life-threatening conditions who lack alternative treatment options and do not qualify for clinical trials.
11
Publications
529
Citations
59
Authors
47
Institutions
Publications per year
2017–2026
5
11
Physician perspectives on compassionate use in pediatric oncology
Scott Moerdler, Lindy Zhang, Elena Gerasimov et al. · Pediatric Blood & Cancer · 2018 · 30 citations
Medicine, Oncology, Pediatrics +13
1–5 of 11
59
1
h-index
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 59
47
Erasmus MC
Rotterdam, The Netherlands
1 h-index
1 publications
21 citations
Johnson University
Knoxville, United States
1 h-index
1 publications
30 citations

Radboud University Nijmegen
Nijmegen, The Netherlands
1 h-index
1 publications
21 citations
The University of Texas MD Anderson Cancer Center
Houston, United States
1 h-index
1 publications
30 citations
Kids' Cancer Project
Alexandria, Australia
1 h-index
2 publications
60 citations
University Medical Center Utrecht
Utrecht, The Netherlands
1 h-index
3 publications
63 citations
Children's Hospital at Montefiore
New York, United States
1 h-index
2 publications
60 citations

Università di Camerino
Camerino, Italy
1 h-index
1 publications
12 citations
1–8 of 47
1 publications · 27 citations
1
h-index
1 publications · 67 citations
1
h-index
1 publications · 18 citations
1
h-index
1 publications · 12 citations
1
h-index
TIRS · 1 publications · 11 citations
1
h-index
1–5